Derm Research Incorporated   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Austin TX United States (1996)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

DermResearch Center of NewYork, Inc. | DermResearch, Inc | DermResearch PLLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Erythema (Phase 3)

Herpes Labialis (Phase 2)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Keratosis, Seborrheic (Phase 2)

Onychomycosis (Phase 2)

Psoriasis (Phase 4)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 12